Author:
Martinez Anthony,Cheng Wei-Han,Marx Steven E.,Manthena Shivaji,Dylla Douglas E.,Wilson Lauren,Thomas Emmanuel
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference39 articles.
1. AASLD, IDSA. Key populations: identification and management of HCV in people who inject drugs. 2021. https://www.hcvguidelines.org/unique-populations/pwid. Accessed 16 June 16.
2. Centers for Disease Control and Prevention. Viral Hepatitis Surveillance Report: United States, 2019.
https://www.cdc.gov/hepatitis/statistics/2019surveillance/index.htm. Accessed 25 May 2023.
3. Falade-Nwulia O, Irvin R, Merkow A, et al. Barriers and facilitators of hepatitis C treatment uptake among people who inject drugs enrolled in opioid treatment programs in Baltimore. J Subst Abuse Treat. 2019;100:45–51.
4. Childs E, Assoumou SA, Biello KB, et al. Evidence-based and guideline-concurrent responses to narratives deferring HCV treatment among people who inject drugs. Harm Reduct J. 2019;16:14.
5. Falade-Nwulia O, Sulkowski MS, Merkow A, Latkin C, Mehta SH. Understanding and addressing hepatitis C reinfection in the oral direct-acting antiviral era. J Viral Hepat. 2018;25:220–7.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献